Usually, the occurrence of an MSI-H profile in IBD-related CRCs is typically attributed to the hypermethylation of the MLH1 gene promoter, which leads to the loss of MLH1 protein expression [85]. The gene discussed is MLH1; the disease is inflammatory bowel disease.